Server was unable to process request. ---> The data types ntext and varchar are incompatible in the equal to operator. Incorrect syntax near ')'. Incorrect syntax near the keyword 'declare'. Khandwala Securities Limited.
NIFTY
41.95  0.42%
 9915.25
S&P BSE SENSEX
124.49  0.39%
 32028.89
Aurobindo Pharma Ltd.
NSE : AUROPHARMA BSE : 524804 ISIN code : INE406A01037
on 21-Jul-2017
NSE
-2.25    -0.3%
Rs. 748.25
 
Days Low
Rs. 733.85
Days High
Rs. 756.1

Open Rs. 755
 
52 week Low
Rs. 504
52 week High
Rs.895
 
 
Bid :                 0.00 (0)
Offer :        747.55 (9)
BSE
Rs.747.55
-2.7    -0.36%
on 21-Jul-2017
BSE
-2.7    -0.36%
Rs. 747.55
 
Days Low
Rs. 733.15
Days High
Rs. 755.9

Open Rs. 755
 
52 week Low
Rs. 503.05
52 week High
Rs.895
 
 
Bid :                 0.00 (0)
Offer :        747.55 (9)
NSE
Rs.748.25
-2.25    -0.3%
 
 
Last Price (Rs.)  747.55 Value  158716433.00
Net Change (Rs.)  -2.70 Best Buy  0.00
Volume  212642 Best Sell  747.55
Prev.Close (Rs.)  750.25 Best Quantity  0
Open (Rs.)  755.00 Sell Quantity  9
High (Rs.)  756.10 52-Week High (Rs.)  895.00
Low (Rs.)  733.85 52-Week Low (Rs.)  504.00
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  437976.39
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital585.20 292.00 291.50 
Share Capital585.20 292.00 291.50 
Share Capital585.20 292.00 291.50 
Share Capital585.20 292.00 291.50 
Share Capital585.20 292.00 291.50 
Currents Investments0.20 196.40 0.30 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 576.60 1383440 86.99 0.00 0.61
Cadila Healthcare 528.10 540638 64.65 81.70 0.61
Lupin 1142.85 516280 323.33 16.43 0.66
Piramal Enterprises 2916.05 503203 835.79 64.78 0.72
Dr. Reddys Lab 2759.75 457624 694.74 33.06 0.72
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Mar 2017Dec 2016Sep 2016
Net Sales24200.9025213.7024101.60
Operating Profit6312.106634.806278.10
PBDT6221.506532.806158.80
Net Profit4554.604410.204192.40
More> 
 
Company News
7/19/2017 12:00:00 AM
Aurobindo Pharma receives USFDA approval for Sevelamer Carbonate table...
7/19/2017 12:00:00 AM
Aurobindo Pharma advances on receiving USFDA approval for Sevelamer Ca...
7/19/2017 12:00:00 AM
Aurobindo Pharma informs about press release
More>
 
Ratios
   Earnings Per Share (Rs)27.68 
   Book NAV/Share(Rs)116.38 
   PAT Margin (%)17.37 
   Asset Turnover(x)0.84 
   PER(x)26.92 
   Yield(%)0.34 
   EV/Core EBITDA(x)17.70 
   M Cap / Sales4.76 
   Net Sales Growth(%)13.23 
   PAT Growth(%)6.81 
   Total Debt/Equity(x)0.49 
   Current Ratio(x)1.54 
   Quick Ratio(x)1.00 
   Total Debt/Mcap(x)0.08 
More>